XL-388

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameXL-388
Drug Alias NameXL-388EXEL-2280EXEL-8232EXEL-6309EXEL-0862 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2
Therapy Area/IndicationsMyeloproliferative Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsMyeloproliferative Disorders

Other Information

ATC CodeN/A
Related LinksN/A